1st Nov 2018 07:23
(Sharecast News) - Smith & Nephew posted a rise in third-quarter revenue on Thursday as it backed its full-year guidance.
Read more8th Aug 2018 15:22
(Sharecast News) - A survey of surgeons by UBS has indicated that Smith & Nephew's share of the orthopaedic surgical robots market will not be as big as first thought, leading to analysts downgrading their rating on the shares.
Read more13th Feb 2017 08:26
(ShareCast News) - Berkeley Group: Barclays reiterates Equal Weight with a target price of 3175p. Flybe Group: HSBC reiterates Buy with a target price of 55p. Esure Group: Berenberg maintains Sell with a target price of 193p. Berendsen: Citigroup reiterates Neutral with a target price of 930p. Sm
Read more10th Feb 2017 17:10
(ShareCast News) - FTSE 100 is higher on Friday afternoon thanks to a string of mining behemoths led by Rio Tinto congregating atop the risers' list, albeit offset by a motley group of fallers led by consumer goods giant Reckitt Benckiser. London's top tier index closed 0.40% higher to 7,258.75 poin
Read more10th Feb 2017 10:35
(ShareCast News) - British American Tobacco: Berenberg upgrades to Buy with a target price of 5670p. Smith & Nephew: Jefferies reiterates Buy with a target price of 1350p. BT Group: UBS maintains Neutral with a target price of 325p. Ashmore Group: UBS maintains Buy with a target price of 390p. Da
Read more9th Feb 2017 07:48
(ShareCast News) - Smith & Nephew reported full year sales and earnings in line with consensus forecasts as growth from the US and most emerging markets struggled to offset weakness in China and flat markets elsewhere. With China having returned to growth in the second half of the year and other eme
Read more19th Jan 2017 16:45
(ShareCast News) - G4S: Barclays upgrades to equal-weight with a target price of 260p. Weir: Credit Suisse reiterates outperform, 2200p target. Coca Cola HBC: Goldman Sachs upgrades to buy with a 2120p target. Diageo: HSBC reiterates buy with a 2600p target. Aveva: Goldman Sachs reiterates sell w
Read more12th Jan 2017 15:45
(ShareCast News) - Smith & Nephew confirmed that chief financial officer Julie Brown left the company earlier in the week, with shares in the company were hit by read across by US rivals and wider healthcare falls. The global medical technology business said that Brown ceased to be a director of th
Read more30th Nov 2016 07:38
(ShareCast News) - Medical devices group Smith & Nephew has appointed Graham Baker as chief financial officer with effect from 1 March 2017. Baker joins the company from generic pharmaceuticals firm Alvogen, where he is currently CFO. Prior to that, he worked for AstraZeneca for 20 years, holding va
Read more25th Nov 2016 17:30
(ShareCast News) - Essentra: Jefferies keeps at buy with a target price of 445p. Rio Tinto: HBSC stays at buy 3300p target. Legal & General: Berenberg reiterates buy with a 301p target. Jardine Lloyd Thomson: HSBC reiterates buy with a 1100p target. Diageo: Credit Suisse keeps at outperform with
Read more22nd Nov 2016 09:56
(ShareCast News) - BT Group: UBS reiterates neutral with a target price of 400p. Tesco: JP Morgan reiterates underweight with a 135p target. Relx: Credit Suisse stays at outperform with a 1600p target. Pets at Home: HSBC reiterates buy with a 320p target. Royal Dutch Shell B: UBS starts coverage
Read more4th Nov 2016 11:02
(ShareCast News) - Coca Cola HBC: Barclays keeps at underweight with a target price of 1630p. Smith & Nephew: Jefferies stays at buy, 1395p target. Merlin Entertainments: Berenberg starts coverage with a 440p target. South 32: Barclays reiterates overweight with a 200p target. Ladbrokes: UBS keep
Read more3rd Nov 2016 11:11
(ShareCast News) - Medical devices group Smith & Nephew, which makes artificial hips and knees, posted a rise in third-quarter revenue thanks to solid performances in the sports medicine joint repair and knee implants divisions. Third-quarter revenue was up 2% on an underlying basis and 1% on a repo
Read more31st Oct 2016 14:23
(ShareCast News) - The FTSE 100 was traipsing lower on Monday afternoon, led down by an assortment of companies across sectors, notably those that are due to report in the coming few days. Shire, which is scheduled to post its third-quarter results on Tuesday, was bottom of the pile as the drug deve
Read more6th Oct 2016 19:13
(ShareCast News) - Cyclicals gained while defensive issues fell back in an overall down market ahead of the release of September“s US non-farm payrolls report the next day. Acting as a backdrop, developed world sovereign bonds dropped to their lowest levels since July as traders continued to react t
Read more